Behavioral treatment of chemotherapy-induced nausea and vomiting.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 8292509)

Published in Oncology (Williston Park) on December 01, 1993

Authors

G R Morrow1, J T Hickok

Author Affiliations

1: University of Rochester Cancer Center, New York.

Articles by these authors

Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin (1989) 1.45

Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med (2000) 1.31

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer (1995) 1.05

Frequency and clinical implications of delayed nausea and delayed emesis. Am J Clin Oncol (1996) 0.99

Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage (2000) 0.99

Sources of information used by patients to learn about chemotherapy side effects. J Cancer Educ (2000) 0.93

Behavioral aspects of clinical trials. An integrated framework from behavior theory. Cancer (1994) 0.93

Vagal changes following cancer chemotherapy: implications for the development of nausea. Psychophysiology (2000) 0.92

Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations. Br J Cancer (2007) 0.90

Initial control of chemotherapy-induced nausea and vomiting in patient quality of life. Oncology (Williston Park) (1998) 0.86

Relationship of gastric myoelectrical and cardiac parasympathetic activity to chemotherapy-induced nausea. J Psychosom Res (2001) 0.77

Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. J Auton Nerv Syst (1999) 0.76